The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
The focus for the new facility will be cancer drugs and research. The hopes here are to provide a link between formulation and commercial manufacturing, in essence better availability to be created for patient accessibility related to clinical trials. BD ABBOTT PARK, Ill., June 12 -- Today...